Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Simple blood test to detect Alzheimer's disease may replace more invasive diagnostic methods

Simple blood test to detect Alzheimer's disease may replace more invasive diagnostic methods

Chan Zuckerberg Initiative funds Notre Dame research on aging and neurodegeneration

Chan Zuckerberg Initiative funds Notre Dame research on aging and neurodegeneration

Study links air pollution with increased Alzheimer's markers

Study links air pollution with increased Alzheimer's markers

Scientists identify new therapeutic approach for combating neurodegenerative diseases

Scientists identify new therapeutic approach for combating neurodegenerative diseases

Ultra-sensitive blood test predicts functional outcome in stroke patients

Ultra-sensitive blood test predicts functional outcome in stroke patients

Single-dose genetic medicine halts the progression of ALS and frontotemporal dementia in mice

Single-dose genetic medicine halts the progression of ALS and frontotemporal dementia in mice

Wastewater clues could revolutionize Alzheimer's detection

Wastewater clues could revolutionize Alzheimer's detection

Researchers introduce a pioneering approach to combat neurodegenerative diseases

Researchers introduce a pioneering approach to combat neurodegenerative diseases

GV1001 exerts anti-aging effects in triple transgenic Alzheimer's mice

GV1001 exerts anti-aging effects in triple transgenic Alzheimer's mice

Experts join forces to define recommendations for biomarker-based diagnosis of Alzheimer’s disease

Experts join forces to define recommendations for biomarker-based diagnosis of Alzheimer’s disease

Study points to herpes simplex virus as a risk factor for dementia

Study points to herpes simplex virus as a risk factor for dementia

D-CARE study highlights inclusive recruitment strategies for diverse dementia care

D-CARE study highlights inclusive recruitment strategies for diverse dementia care

Study links Agent Orange exposure to neurodegenerative diseases

Study links Agent Orange exposure to neurodegenerative diseases

Researchers develop 20 new recombinant rabies viral vectors for brain circuit mapping

Researchers develop 20 new recombinant rabies viral vectors for brain circuit mapping

Antiseptic mouthwash reduces periodontitis bacteria in diabetes patients

Antiseptic mouthwash reduces periodontitis bacteria in diabetes patients

Neural prosthetic device successfully used to recall specific memories

Neural prosthetic device successfully used to recall specific memories

Diabetes management program cuts dementia risk in type 2 patients

Diabetes management program cuts dementia risk in type 2 patients

Proteomic biomarkers in blood plasma as predictors of dementia in healthy individuals

Proteomic biomarkers in blood plasma as predictors of dementia in healthy individuals

Study finds erectile dysfunction drugs linked to lower Alzheimer's risk

Study finds erectile dysfunction drugs linked to lower Alzheimer's risk

Unlocking Alzheimer's secrets: Study pinpoints APOE4's harmful effect on lipids

Unlocking Alzheimer's secrets: Study pinpoints APOE4's harmful effect on lipids

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.